Quantoom, DNA Script and EVA Pharma link up in renewed push to bring mRNA vaccine autonomy to Africa and beyond
Egypt's EVA Pharma, France’s DNA Script and Belgium’s Quantoom Biosciences on Wednesday unveiled a new collaboration to develop a “digital-to-biologics, end-to-end mRNA production platform." If successful, the platform could pitch in on the Africa CDC’s goal to boost local vaccine production to 60% of the region's demand by 2040.
Egypt's EVA Pharma, France’s DNA Script and Belgium’s Quantoom Biosciences on Wednesday unveiled a new collaboration to develop a “digital-to-biologics, end-to-end mRNA production platform." If successful, the platform could pitch in on the Africa CDC’s goal to boost local vaccine production to 60% of the region's demand by 2040.
